Ben Pouladian, CEO of BEP Holdings, to Join ISPE Los Angeles Biomanufacturing Panel

LOS ANGELES - EntSun -- LOS ANGELES, CA –– BEP Holdings announced today that its CEO, Ben Pouladian (LinkedIn (https://www.linkedin.com/in/benpouladian), X (https://x.com/benitoz)), will be a featured panelist at the ISPE Greater Los Angeles Area Chapter's upcoming "Resilient Life Sciences Ecosystem & Continuous Drug Discovery" program on July 9, 2025 (see LinkedIn panel announcement (https://www.linkedin.com/)). The International Society for Pharmaceutical Engineering (ISPE) Greater LA Chapter event, hosted at JLL's downtown Los Angeles office, will convene industry leaders to discuss strengthening biomanufacturing and life sciences innovation in the region.

Pouladian is an engineer-turned-entrepreneur and investor who leads BEP Holdings, a firm focused on life science ventures and infrastructure. Under his leadership, BEP Holdings has helped create much-needed lab space for technological research and development in the local biotech community , bridging critical infrastructure gaps in Los Angeles's life science sector. Pouladian also serves on the Leadership Board of the Terasaki Institute for Biomedical Innovation , a nonprofit research organization, reflecting his commitment to advancing medical research and innovation.

More on EntSun News

• The Citizens Commission on Human Rights Annual Purple Heart Day Event will be Hosted at the Historic Fort Harrison
• Blake Harris the Leading Authority in International Asset Protection Joins Tom Hegna on "Financial Freedom with Tom Hegna"
• Psychedelics for Vets? CCHR Cites History of Exploitation and Failed Science
• GreenPal Empowers Lawn Care Pros Leveraging AI, Surpasses 5 Million Transactions
• Santa Monica Businesses Push Back on Bus Stop Relocation That Threatens Access and Safety

Pouladian's dedication to the life sciences is deeply personal. He lost his father to liver cancer and later his mother to non-small cell lung cancer —experiences that galvanized his mission to support life-saving innovations in healthcare. "After losing both my parents to cancer, I made it my mission to help advance better outcomes and therapies for others," said Pouladian. "By investing in innovative biotech companies and critical lab infrastructure, we can accelerate the development of new treatments so that families don't have to endure what mine did."

About BEP Holdings: BEP Holdings is a Los Angeles-based private investment firm dedicated to fostering innovation in life sciences and advanced technologies. The firm invests in early-stage biotech and pharmaceutical ventures and develops state-of-the-art laboratory facilities to support cutting-edge research. Under the leadership of CEO Ben Pouladian, BEP Holdings aims to accelerate the development of life-saving therapies by bridging gaps in resources and infrastructure within Southern California's life science ecosystem.